Efficient Robotics commercializes NTP screening for quickly screening biomolecules

In Germany, the global biotechnology research and development community now has a commercial breakthrough microfluidic platform that revolutionizes the process of ultra-high throughput screening for the optimization of enzymes, antibodies, proteins, microbial strains and mammalian cells. Efficient Robotics GmbH has announced the commercialization of its Nano-Titer-Pipe (NTP) Screening Workstation for screening and optimizing millions of biomolecules and cells in hours and days as opposed to conventional technologies, that takes weeks and even months. Gone are the days where the biotechnology industry needs to depend only on conventional “robotic arm” screening technology, the NTP Screening Workstation from Efficient Robotics GmbH is faster and more cost-effective than conventional technologies.

Efficient Robotics GmbH has global biochemistry markets under commercial evaluation however the company has experienced significant commercial interest coming from the biotechnology sector in the European Union and the United States. “The sheer speed of the NTP Screening Workstation reduces development times of improved cells and biomolecules from months to days and with its low acquisition

cost it is a very attractive technology solution for applications in directed evolution, strain and cell line development and many more biotech selection processes” said Martin Mitchell, Director of Global Sales and Marketing.

Efficient Robotics is a leading company for the development, production and commercialization of automated microfluidic systems for the pharmaceutical, biotechnology and chemical industries. Efficient Robotics has the NTP Screening Workstation ready for global commercial deployment installation and commissioning. For more technical and commercial information including a technology video please visit www.efficient-robotics.com/video.